Tretazicar

未知生产厂商

Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Method of combating infection
US 8415334 B2申请人: BURKE PHILIP JOHN优先权: 2005
CN
US
3 件公开
VERMIN POISON
US 2010166871 A1申请人: KNOX RICHARD J优先权: 2006
US